Suzan Stelloo

1.6k total citations
23 papers, 603 citations indexed

About

Suzan Stelloo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Suzan Stelloo has authored 23 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Suzan Stelloo's work include Prostate Cancer Treatment and Research (11 papers), Genomics and Chromatin Dynamics (8 papers) and Cancer, Lipids, and Metabolism (5 papers). Suzan Stelloo is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Genomics and Chromatin Dynamics (8 papers) and Cancer, Lipids, and Metabolism (5 papers). Suzan Stelloo collaborates with scholars based in Netherlands, United States and United Kingdom. Suzan Stelloo's co-authors include Wilbert Zwart, Andries M. Bergman, Ekaterina Nevedomskaya, Lodewyk F.A. Wessels, Henk G. van der Poel, Jeroen de Jong, Yongsoo Kim, Michiel Vermeulen, Karianne Schuurman and Guido Jenster and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Cell.

In The Last Decade

Suzan Stelloo

21 papers receiving 601 citations

Peers

Suzan Stelloo
Chuandong Geng United States
Lara K. Boyd United Kingdom
Suhaida A. Selamat United States
Sophia X. Pfister United Kingdom
Chuandong Geng United States
Suzan Stelloo
Citations per year, relative to Suzan Stelloo Suzan Stelloo (= 1×) peers Chuandong Geng

Countries citing papers authored by Suzan Stelloo

Since Specialization
Citations

This map shows the geographic impact of Suzan Stelloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzan Stelloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzan Stelloo more than expected).

Fields of papers citing papers by Suzan Stelloo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzan Stelloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzan Stelloo. The network helps show where Suzan Stelloo may publish in the future.

Co-authorship network of co-authors of Suzan Stelloo

This figure shows the co-authorship network connecting the top 25 collaborators of Suzan Stelloo. A scholar is included among the top collaborators of Suzan Stelloo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzan Stelloo. Suzan Stelloo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Haoyu, Annie Yang, Suzan Stelloo, et al.. (2025). Multi-omics analysis reveals distinct gene regulatory mechanisms between primary and organoid-derived human hepatocytes. Disease Models & Mechanisms. 18(1). 1 indexed citations
2.
Kojić, Aleksandar, Marlous Hoogstraat, Karianne Schuurman, et al.. (2025). Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations. Genome biology. 26(1). 124–124. 1 indexed citations
3.
Stelloo, Suzan, Daniel V. Bax, Marijke Baltissen, et al.. (2025). PRC1 and PRC2 proximal interactome in mouse embryonic stem cells. Cell Reports. 44(3). 115362–115362. 2 indexed citations
5.
Stelloo, Suzan, Cristina Furlan, Pascal W.T.C. Jansen, et al.. (2024). Deciphering lineage specification during early embryogenesis in mouse gastruloids using multilayered proteomics. Cell stem cell. 31(7). 1072–1090.e8. 4 indexed citations
6.
Flórez‐Grau, Georgina, Ghaith Bakdash, Rutger J. Röring, et al.. (2024). Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential. Cell Reports Medicine. 5(2). 101386–101386. 14 indexed citations
7.
Linder, Simon, Tesa Severson, Ekaterina Nevedomskaya, et al.. (2023). Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs. European Urology. 84(5). 455–460. 3 indexed citations
8.
Stelloo, Suzan, J. Brake, Sophie K. Horrevorts, et al.. (2023). Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways. Journal of Biological Chemistry. 299(11). 105276–105276. 9 indexed citations
9.
Gräwe, Cathrin, et al.. (2020). RNA-Centric Methods: Toward the Interactome of Specific RNA Transcripts. Trends in biotechnology. 39(9). 890–900. 21 indexed citations
10.
Augello, Michael A., Deli Liu, Lesa D. Deonarine, et al.. (2019). CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis. Cancer Cell. 35(4). 603–617.e8. 83 indexed citations
11.
Vis, Daniël J., Suzan Stelloo, Cor Lieftink, et al.. (2019). TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth. eLife. 8. 25 indexed citations
12.
Stelloo, Suzan, Andries M. Bergman, & Wilbert Zwart. (2019). Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers. Endocrine Related Cancer. 26(5). R267–R285. 19 indexed citations
13.
Singh, Abhishek A., Karianne Schuurman, Ekaterina Nevedomskaya, et al.. (2018). Optimized ChIP-seq method facilitates transcription factor profiling in human tumors. Life Science Alliance. 2(1). e201800115–e201800115. 28 indexed citations
14.
Stelloo, Suzan, Ekaterina Nevedomskaya, Yongsoo Kim, et al.. (2018). Integrative epigenetic taxonomy of primary prostate cancer. Nature Communications. 9(1). 4900–4900. 82 indexed citations
15.
Stelloo, Suzan, Ekaterina Nevedomskaya, Yongsoo Kim, et al.. (2017). Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis. Oncogene. 37(3). 313–322. 67 indexed citations
16.
Stelloo, Suzan, Joyce Sanders, Ekaterina Nevedomskaya, et al.. (2016). mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma. Oncotarget. 7(22). 32916–32924. 11 indexed citations
17.
Stelloo, Suzan, Ekaterina Nevedomskaya, Henk G. van der Poel, et al.. (2015). Androgen receptor profiling predicts prostate cancer outcome. EMBO Molecular Medicine. 7(11). 1450–1464. 65 indexed citations
18.
Nevedomskaya, Ekaterina, Suzan Stelloo, Henk G. van der Poel, et al.. (2015). Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer. Genomics Data. 7. 124–126. 13 indexed citations
19.
Rosell, Meritxell, Ekaterina Nevedomskaya, Suzan Stelloo, et al.. (2014). Complex Formation and Function of Estrogen Receptor α in Transcription Requires RIP140. Cancer Research. 74(19). 5469–5479. 21 indexed citations
20.
Schackmann, Ron C.J., Sjoerd Klarenbeek, Eva J. Vlug, et al.. (2013). Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling. Cancer Research. 73(15). 4937–4949. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026